Targeted drug delivery revolutionises treatment by focusing medications on specific tissues, reducing the impact on healthy cells. Scientists enhance this precision with carriers like microspheres and nanoparticles, controlling release and absorption. Microspheres, made from biodegradable proteins or polymers, sustain drug release, making them ideal for targeted therapies, especially in oncology. Beyond drug delivery, microspheres open new possibilities across industries—from next-gen coatings to thermal insulation. With tailored sizes, shapes, and materials, they drive advancements in pharmaceuticals, advanced materials, and more.

Biomedical and research applications

Fluorescent microspheres are gaining traction in biomedical research, aiding in-process testing, virus simulations, and diagnostics. Refined microspheres generally meet the high optical and quality standards for rigorous biomedical research, supporting reliable diagnostics and precise experimental outcomes. This adaptability has allowed microspheres to become reliable markers in various scientific investigations.

Applications in coatings, composites, and insulation

Beyond medicine, microspheres—particularly ceramic varieties—are increasingly used in coatings and thermal insulation. Lightweight and hollow ceramic microspheres are prized for their insulation properties and are found in a range of materials, from building composites to specialised paints

Market growth and future projections

Microsphere technology is rapidly growing, with projections indicating increased demand across sectors, particularly for hollow and specialised microspheres. Financial projections vary, yet conservative estimates suggest the global market for microspheres will top $12 billion by 2029. Reports also suggest that hollow microspheres will continue leading the market for the foreseeable future.

Reference:

Emerging Trends in Microsphere Technology

READ MORE
Exim rebrands as ExSyn: We celebrate our 30-year heritage with a new brand and website that bring alive our values and purpose
News · 27/03/2021

Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.

In focus: Teprenone (Geranylgeranylacetone; GGA)
Products in focus · 31/03/2026

Teprenone (Geranylgeranylacetone, GGA) is a mixture of the all-trans and mono-cis isomers of 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one (in a weight ratio of 3:2). It is an acyclic isoprenoid compound with a structure like retinoids and is widely used for the treatment of gastrointestinal ulcers.

In focus: Ciclopirox Olamine Ph.Eur.
Products in focus · 24/03/2026

Ciclopirox Olamine (CPO)  is the N-oxide of a 2 -hydroxy pyridine derivative that carries antifungal, antibacterial, and anti-inflammatory properties. It is composed of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone combined with 2 aminoethanol (olamine) in a 1:1 ratio.

In focus: N,N-Dimethylglycine sodium salt (DMG Na)
Products in focus · 17/03/2026

N,N-Dimethylglycine sodium salt (DMG Na) is the sodium salt form of N,N-dimethylglycine, a tertiary amino acid derivative is white to off white crystalline solid, freely soluble in water.